Reconstitution of isolated Ca(2+)-activated K+ channel proteins from basolateral membranes of rabbit colonocytes

Have we enough glutamine and how does it work? A clinician's view

There is a gap between the scientific basis of the claim that in several disease states glutamine is lacking and the widespread belief that supplementation of glutamine to the nutritional regimen is beneficial in severely ill patients. Glutamine shortage exists when consuming tissues, playing a crucial role in the response to trauma and disease, receive insufficient amounts of glutamine. In these tissues (immune system, wound), glutamine is only partly oxidized but has more specific roles as nontoxic nitrogen carrier, precursor of several crucial metabolites required for cell proliferation and for maintenance of the redox potential, and as osmolyte. In inflammatory states, glutamine concentrations in plasma and tissues are decreased due to many disease-related factors, precluding its use as a reliable indicator of shortage. Isotope studies have yielded equivocal results, precluding their use as a reliable indicator of glutamine shortage or adequacy. The increase in the net release of glutamine from peripheral tissues to central tissues (immune system, liver, spleen, wound) in inflammatory states provides a better basis for the necessity to supplement the organism with extra glutamine in these conditions. Glutamine supplementation was beneficial in a few studies in burn or trauma patients. The clinical benefit of parenteral glutamine supplementation in patients with severe inflammation has been demonstrated more convincingly. The amounts of glutamine supplemented approximate the amounts released by peripheral tissues and utilized by central organs operative in host defense and are therefore in the physiological range.

Purification and characterization of epithelial Ca(2+)-activated K+ channels

Reabsorption of NaCl in the thick ascending limb of Henle's loop in the kidney and in the surface cells in the distal colon involves the integrated function of several membrane transport systems including ion channels, the Na,K,Cl-cotransport system and the Na,K-pump. To determine if their properties are consistent with a role in regulation of transepithelial transport, Ca(2+)-activated K+ channels from the luminal membrane of the TAL cells and from the basolateral membrane of the distal colon cells have been characterized by flux studies in plasma membrane vesicle preparations and by single channel measurements in lipid bilayers. The channels are found to be activated by Ca2+ in the physiological range of concentration with a strong dependence on intracellular pH and the membrane potential. The Ca(2+)-sensitivity of the K+ channels is modulated by phosphorylation and dephosphorylation and the K+ channel protein must be in a phosphorylated state to respond to intracellular concentrations of Ca2+. As a step towards purification of the K+ channel proteins, procedures for solubilization and reconstitution of the K+ channels have been developed. The observation that the epithelial Ca(2+)-activated K+ channels bind calmodulin in the presence of Ca2+ have allowed for partial purification of the K+ channel proteins by calmodulin affinity chromatography. In the sequences for the two cloned Ca(2+)-activated K+ channels, the mSlo channel and the slowpoke channel, putative calmodulin binding regions can be identified.